Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$24.86 - $35.02 $155,971 - $219,715
-6,274 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$26.38 - $51.15 $165,508 - $320,915
6,274 New
6,274 $209,000
Q3 2020

Nov 12, 2020

SELL
$3.61 - $9.87 $22,649 - $61,924
-6,274 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$2.65 - $4.03 $16,626 - $25,284
6,274 New
6,274 $22,000
Q1 2020

May 08, 2020

SELL
$2.36 - $5.26 $23,201 - $51,711
-9,831 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$4.6 - $5.57 $45,222 - $54,758
9,831 New
9,831 $51,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $443M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Citizens Financial Group Inc Portfolio

Follow Citizens Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.